 |
 |
Michael J. Fox Foundation Awards Grant To Israeli Researcher November 16, 2003 Nov. 16 - The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the National Institute of Neurological Disorders and Stroke (NINDS) have joined efforts to create a consortium for testing candidate drugs with potential neuroprotective benefits. The drugs will be tested on a variety of rodent models spanning several neurodegenerative diseases such as Parkinson's disease, ALS, and Huntington's disease. As part of the consortium, the Foundation has awarded grants to five research projects including a Technion - Israel Institute of Technology scientist Moussa Youdim. Youdim's project is entitled "Ironing Iron Out in Parkinsonian Rodents Models with Brain Permeable Iron Chelators". NINDS initiated the program with a $1 million dollar commitment to create a consortium to identify new treatments for neurodegenerative disorders through the testing of promising drugs identified or evaluated in ongoing peer-reviewed projects. Seeing an opportunity to increase focus on Parkinson's disease as well as open the applicant pool to non-NINDS grantees, MJFF joined the NINDS effort. Approximately 40 candidate neuroprotective drugs will be tested in the consortium through 15 NINDS-funded supplement grants and five MJFF-funded awards. In all, MJFF pledged $263,000 to this program, and more than doubled the number of drugs tested in PD models, for a total of approximately 17 drugs. SOURCE: Israel 21C, CA http://tinyurl.com/va8y * * * ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn